RECURRENT OVARIAN EPITHELIAL CANCER

Clinical trials for RECURRENT OVARIAN EPITHELIAL CANCER explained in plain language.

Never miss a new study

Get alerted when new RECURRENT OVARIAN EPITHELIAL CANCER trials appear

Sign up with your email to follow new studies for RECURRENT OVARIAN EPITHELIAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Diabetes drug tested to boost chemo against aggressive cancers

Disease control Completed

This study tested whether adding the common diabetes medication metformin to standard chemotherapy could better control advanced cancers of the ovary, fallopian tube, or abdominal lining. It involved 111 non-diabetic patients who were randomly assigned to receive either metformin…

Matched conditions: RECURRENT OVARIAN EPITHELIAL CANCER

Phase: PHASE2 • Sponsor: University of Chicago • Aim: Disease control

Last updated Apr 03, 2026 14:42 UTC

RECURRENT OVARIAN EPITHELIAL CANCER

Get alerted when new RECURRENT OVARIAN EPITHELIAL CANCER trials appear

Diabetes drug tested to boost chemo against aggressive cancers